Alyeska Investment Group’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-551,058
Closed -$22.9M 635
2025
Q4
$22.9M Buy
+551,058
New +$22.4M 0.06% 297
2025
Q3
Sell
-222,833
Closed -$11.8M 609
2025
Q2
$11.8M Sell
222,833
-292,091
-57% -$15.4M 0.04% 338
2025
Q1
$28.7M Buy
514,924
+26,746
+5% +$1.28M 0.11% 208
2024
Q4
$21.1M Buy
+488,178
New +$21.7M 0.08% 254
2023
Q4
Sell
-129,765
Closed -$10.4M 538
2023
Q3
$10.4M Buy
+129,765
New +$10.2M 0.07% 277
2021
Q4
Sell
-270,802
Closed -$47.9M 623
2021
Q3
$47.9M Sell
270,802
-37,086
-12% -$6.14M 0.59% 37
2021
Q2
$49.5M Buy
307,888
+217,003
+239% +$33.4M 0.57% 40
2021
Q1
$13.6M Sell
90,885
-71,802
-44% -$8.7M 0.18% 165
2020
Q4
$16.1M Buy
+162,687
New +$16.3M 0.23% 135

Other funds holding CNXC

Alyeska Investment Group's CNXC Position: Q1 2026 in Review

Alyeska Investment Group sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 551,058 shares — an estimated $22.9M sold.

Alyeska Investment Group first reported a position in CNXC in Q4 2020 and held it in 9 quarters. The position peaked at $49.5M in Q2 2021. 304 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Alyeska Investment Group reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 551,058 Concentrix shares in Q1 2026, an estimated $22.9M.
  • Alyeska Investment Group first reported a position in Concentrix in Q4 2020 and held it in 9 quarters.
  • Alyeska Investment Group's Concentrix position peaked at $49.5M in Q2 2021.
  • 304 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.